Hemodialysis and Peritoneal Dialysis Market Size & Trends 2028
The hemodialysis and peritoneal dialysis market is projected to reach US$ 130,370.18 million by 2028 from US$ 89,851.61 million in 2022; it is expected to grow at a CAGR of 6.4% from 2022 to 2028.
There are two kinds of dialysis. In hemodialysis, blood is pumped out of patient's body to an artificial kidney machine and returned to the patient's body by tubes connected to the machines. In peritoneal dialysis, the inside lining of patient's own belly acts as a natural filter.
The hemodialysis and peritoneal dialysis market is segmented on the basis of type, product, end user, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The hemodialysis and peritoneal dialysis market report offers insights and in-depth analysis of the market, emphasizing parameters such as market size, trends, technological advancements, and market dynamics, as well as the analysis of the competitive landscape of the globally leading market players. Furthermore, the report includes the impact of the COVID-19 pandemic on the hemodialysis and peritoneal dialysis market across all the regions.
The growth of the hemodialysis and peritoneal dialysis market is attributed to the increase in the number of ESRD patients, rise in incidence of kidney failure and chronic renal dysfunction among population, and dearth of organ donors. However, the reimbursement concerns in emerging markets restrict the market growth.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Hemodialysis and Peritoneal Dialysis Market: Strategic Insights
Hemodialysis and Peritoneal Dialysis Market
-
CAGR (2022 - 2028)
6.4%
-
Market Size 2022
US$ 89.85 Billion
-
Market Size 2028
US$ 130.37 Billion
Market Dynamics
GROWTH DRIVERS
- XXXXXXX
- XXXXXXX
- XXXXXXX
FUTURE TRENDS
- XXXXXXX
- XXXXXXX
- XXXXXXX
OPPORTUNITIES
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- Fresenius Medical Care AG Co KGaA
- DaVita Inc
- Baxter International Inc
- B Braun Melsungen AG
- Diaverum
- Nipro Medical Corporation
- Evoqua Water Technologies LLC Mar Cor Purification
- Asahi Kasei Medical Co Ltd
- Rockwell Medical Inc
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Type
- Hemodialysis and Peritoneal Dialysis
Product
- Devices
- Consumables
- Services
End User
- Hospital-Based and Home-Based
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Hemodialysis and Peritoneal Dialysis Market: Strategic Insights
-
CAGR (2022 - 2028)6.4% -
Market Size 2022
US$ 89.85 Billion -
Market Size 2028
US$ 130.37 Billion
Market Dynamics
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- Fresenius Medical Care AG Co KGaA
- DaVita Inc
- Baxter International Inc
- B Braun Melsungen AG
- Diaverum
- Nipro Medical Corporation
- Evoqua Water Technologies LLC Mar Cor Purification
- Asahi Kasei Medical Co Ltd
- Rockwell Medical Inc
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
- Hemodialysis and Peritoneal Dialysis
- Devices
- Consumables
- Services
- Hospital-Based and Home-Based
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Market Insights
Increasing Prevalence of Kidney Diseases Drives Hemodialysis and Peritoneal Dialysis Market Growth
Chronic kidney disease (CKD) and acute kidney injury (AKI) are conditions in which the kidneys are damaged and cannot filter blood properly. Because of this, excess fluid and waste from blood remain in the body, which may cause other health problems such as heart disease and stroke. CKD usually worsens over time, even though treatment has shown slow progression. If CKD is left untreated, it can progress to kidney failure and early cardiovascular disease. In CKD, when the kidneys stop working, dialysis or kidney transplant is needed for survival. When treated with dialysis or kidney transplant, this kidney failure is called end-stage renal disease (ESRD). According to the Centers for Disease Control and Prevention (CDC), approximately 36 million adults are suffering from CKD in the US. Further, every 24 hours, 360 people begin dialysis treatment for kidney failure. In 2017, 697.5 million cases of CKD (all stages) were recorded worldwide, for a global prevalence of 9.1%. The increasing prevalence of ESRD is also one of the major factors driving the market. For instance, according to the United States Renal Data System (USRDS), nearly 786,000 people in the country are living with end-stage kidney disease (ESKD), also known as an end-stage renal disease (ESRD). Thus, the increasing prevalence of chronic kidney disease, acute kidney injury, and end-stage renal disease, which leads to the condition of dialysis, is driving the hemodialysis and peritoneal dialysis market.
Type-Based Insights
Based on type, the hemodialysis and peritoneal dialysis market is bifurcated into hemodialysis and peritoneal dialysis. In 2022, the hemodialysis segment held a larger share of the market. Moreover, the same segment is expected to register a higher CAGR of 6.7% during the forecast period.
Product-Based Insights
Based on product, the hemodialysis and peritoneal dialysis market is segmented into devices, consumables, and services. The services segment held the largest market share in 2022. However, the consumables segment is anticipated to register the highest CAGR of 7.5% during the forecast period.
End User-Based Insights
Based on end user, the hemodialysis and peritoneal dialysis market is segmented into hospital-based and home-based. The hospital-based segment held a larger share in 2022. However, the home-based segment is expected to register a higher CAGR of 7.4% during the forecast period.
The hemodialysis and peritoneal dialysis market players adopt organic strategies, such as product launch and expansion, to expand their footprint and product portfolio worldwide, as well as to meet the growing demands.
Hemodialysis and Peritoneal Dialysis Market Report Scope
Report Attribute
Details
Market size in 2022
US$ 89.85 Billion
Market Size by 2028
US$ 130.37 Billion
Global CAGR (2022 - 2028)
6.4%
Historical Data
2020-2021
Forecast period
2023-2028
Segments Covered
By Type - Hemodialysis and Peritoneal Dialysis
By Product - Devices
- Consumables
- Services
By End User - Hospital-Based and Home-Based
Regions and Countries Covered
North America - US
- Canada
- Mexico
Europe - UK
- Germany
- France
- Russia
- Italy
- Rest of Europe
Asia-Pacific - China
- India
- Japan
- Australia
- Rest of Asia-Pacific
South and Central America - Brazil
- Argentina
- Rest of South and Central America
Middle East and Africa - South Africa
- Saudi Arabia
- UAE
- Rest of Middle East and Africa
Market leaders and key company profiles
- Fresenius Medical Care AG Co KGaA
- DaVita Inc
- Baxter International Inc
- B Braun Melsungen AG
- Diaverum
- Nipro Medical Corporation
- Evoqua Water Technologies LLC Mar Cor Purification
- Asahi Kasei Medical Co Ltd
- Rockwell Medical Inc
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 89.85 Billion |
Market Size by 2028 | US$ 130.37 Billion |
Global CAGR (2022 - 2028) | 6.4% |
Historical Data | 2020-2021 |
Forecast period | 2023-2028 |
Segments Covered |
By Type
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
|
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
By Geography
Based on geography, the hemodialysis and peritoneal dialysis market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). A few of the leading players involved in the market are Fresenius Medical Care AG & Co KGaA; DaVita Inc.; Baxter International Inc.; B. Braun Melsungen AG; Diaverum; Nipro Medical Corporation; Asahi Kasei Medical Co., Ltd.; Rockwell Medical, Inc.; and Dialife SA.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Product, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Global hemodialysis and peritoneal dialysis market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. In North America, the U.S. is the largest market for transport media. The US is estimated to hold the largest share in the hemodialysis and peritoneal dialysis market during the forecast period. The rising prevalence of chronic kidney disease and healthcare spending by Medicare contributes to the market's growth. However, the prevalence of chronic kidney disease (CKD) that demands promising diagnostic test options in the Asia-Pacific is expected to account for the fastest growth of the region during the coming years
The hemodialysis and peritoneal dialysis market majorly consists of the players such as Fresenius Medical Care AG & Co KGaA; DaVita Inc.; Baxter International Inc.; B. Braun Melsungen AG; Diaverum; Nipro Medical Corporation; Evoqua Water Technologies LLC. (Mar Cor Purification); Asahi Kasei Medical Co., Ltd.; Rockwell Medical, Inc.; Dialife SA; amongst others.
The hospital-based segment dominated the global hemodialysis and peritoneal dialysis market and held the largest revenue share of 84.16% in 2022.
The hemodialysis segment dominated the global hemodialysis and peritoneal dialysis market and held the largest revenue share of 86.09% in 2022.
The services segment dominated the global hemodialysis and peritoneal dialysis market and held the largest revenue share of 60.98% in 2022.
Hemodialysis and peritoneal dialysis are performed for patients suffering from chronic kidney disease and acute kidney injury. Hemodialysis helps in removing waste from body such as urea from the blood, along with maintaining proper balance of electrolytes in the blood. Peritoneal dialysis procedures are conducted in lining of the abdomen to filter the blood in people who suffer from kidney failures.
Key factors that are driving the growth of this market are increasing prevalence of kidney diseases, and increasing prevalence of diabetes.
The List of Companies - Hemodialysis And Peritoneal Dialysis Market
- Fresenius Medical Care AG & Co KGaA
- DaVita Inc.
- Baxter International Inc.
- B. Braun Melsungen AG
- Diaverum
- Nipro Medical Corporation
- Evoqua Water Technologies LLC. (Mar Cor Purification)
- Asahi Kasei Medical Co., Ltd.
- Rockwell Medical, Inc.
- Dialife SA